8-KThe WireStrategic
Material Agreement · Equity Issuance
Filed Nov 12, 2019 · 6y ago · Accession 0001104659-19-062177
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Corvus Pharmaceuticals, Inc.
- Ticker
- CRVS
- CIK
- 1626971
- Form type
- 8-K
- Filing date
- Nov 12, 2019
- Report date
- Nov 8, 2019
- Document
- a19-22348_18k.htm
- Size
- 274 KB